53 results
424B5
7zsdl7tg3ts pucu
15 Jun 23
Prospectus supplement for primary offering
4:12pm
8-K
EX-99.1
jp1wr8v
9 Nov 22
Zentalis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Updates
7:04am
8-K
EX-99.1
8tsm j7bndwyg5zs
9 Aug 22
Zentalis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update
12:00am
424B5
hrktw
16 May 22
Prospectus supplement for primary offering
5:17pm
8-K
EX-99.1
fmklczs6udk71ulc
5 May 22
Zentalis Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Update
7:05am
424B5
86g gk4xtjtegg2f6n9z
27 Apr 22
Prospectus supplement for primary offering
4:15pm
8-K
84kk60xb3bq
27 Apr 22
Zentalis Pharmaceuticals Announces $25 Million Equity Investment from Pfizer
4:09pm
8-K
EX-99.1
m5wmvzlw73ib
27 Apr 22
Zentalis Pharmaceuticals Announces $25 Million Equity Investment from Pfizer
4:09pm
8-K
EX-99.1
pch a5afxlgjfpl7zm
11 Apr 22
Zentalis Pharmaceuticals Announces Overview of Clinical and Preclinical Data Presented at AACR
4:43pm
8-K
4ya09aqo 4k
8 Apr 22
Zentalis Pharmaceuticals Announces Positive Initial Clinical Data on ZN-c3, its Wee1 Inhibitor, in Patients with Advanced Ovarian Cancer at AACR
5:05pm